Literature DB >> 28103401

Maintenance and Reach of Exposure Psychotherapy for Posttraumatic Stress Disorder 18 Months After Training.

Craig S Rosen1,2, Afsoon Eftekhari1, Jill J Crowley1, Brandy N Smith1, Eric Kuhn1,2, Lindsay Trent1,2, Nicole Martin1, Thuy Tran1, Josef I Ruzek3.   

Abstract

This study examined aspects of clinicians' work environment that facilitated sustained use of prolonged exposure (PE) therapy. Surveys were completed by 566 U.S. Department of Veterans Affairs clinicians 6 and 18 months after intensive training in PE. The number of patients treated with PE at 18 months (reach) was modeled as a function of clinician demographics, clinician beliefs about PE, and work context factors. There were 342 clinicians (60.4%) who used PE at 6 and 18 months after training, 58 (10.2%) who used PE at 18 but not 6 months, 95 (16.7%) who used PE at 6 but not 18 months, and 71 (12.5%) who never adopted PE. Median reach was 12% of clinicians' appointments with patients with posttraumatic stress disorder. Reach was predicted by flow of interested patients (incident response ratio [IRR] = 1.21 to 1.51), PE's perceived effectiveness (IRR = 1.04 to 1.31), working in a PTSD specialty clinic (IRR = 1.06 to 1.26), seeing more patients weekly (IRR = 1.04 to 1.25), and seeing fewer patients in groups (IRR = 0.83 to 0.99). Most clinicians trained in PE sustained use of the treatment, but on a limited basis. Strategies to increase reach of PE should address organizational barriers and patient engagement.
Copyright © 2017 International Society for Traumatic Stress Studies.

Entities:  

Mesh:

Year:  2017        PMID: 28103401     DOI: 10.1002/jts.22153

Source DB:  PubMed          Journal:  J Trauma Stress        ISSN: 0894-9867


  3 in total

1.  Factors Associated With Receipt of Cognitive-Behavioral Therapy or Prolonged Exposure Therapy Among Individuals With PTSD.

Authors:  Carissa van den Berk Clark; Rachel Moore; Scott Secrest; Peter Tuerk; Sonya Norman; Ursula Myers; Patrick J Lustman; F David Schneider; Jacqueline Barnes; Randy Gallamore; Muhammad Ovais; James Alex Plurad; Jeffrey F Scherrer
Journal:  Psychiatr Serv       Date:  2019-04-23       Impact factor: 3.084

2.  PTSD / substance use disorder comorbidity: Treatment options and public health needs.

Authors:  Lisa M Najavits; H Westley Clark; Carlo C DiClemente; Marc N Potenza; Howard J Shaffer; James L Sorensen; Matthew T Tull; Allen Zweben; Joan E Zweben
Journal:  Curr Treat Options Psychiatry       Date:  2020-09-24

3.  The effects of a prolonged exposure workshop with and without consultation on provider and patient outcomes: a randomized implementation trial.

Authors:  Edna B Foa; Carmen P McLean; Lily A Brown; Yinyin Zang; David Rosenfield; Laurie J Zandberg; Wayne Ealey; Brenda S Hanson; Lora Rose Hunter; Ivett J Lillard; Thomas J Patterson; Julio Rosado; Valerie Scott; Charles Weber; Joseph E Wise; Charles D Zamora; Jim Mintz; Stacey Young-McCaughan; Alan L Peterson
Journal:  Implement Sci       Date:  2020-07-29       Impact factor: 7.327

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.